Cas 1150311-30-0,3-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-(2-oxopropyl)-1H-pyrazole-4-carboxamide

1150311-30-0

Post Buying Request

Basic information

Product Name: 3-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-(2-oxopropyl)-1H-pyrazole-4-carboxamide
Synonyms:
CAS NO:1150311-30-0
Molecular Formula:
Molecular Weight: 546.84
EINECS: N/A
Product Categories: N/A
Mol File: 1150311-30-0.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-(2-oxopropyl)-1H-pyrazole-4-carboxamide(CAS DataBase Reference)
NIST Chemistry Reference: 3-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-(2-oxopropyl)-1H-pyrazole-4-carboxamide(1150311-30-0)
EPA Substance Registry System: 3-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-(2-oxopropyl)-1H-pyrazole-4-carboxamide(1150311-30-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1150311-30-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1150311-30-0 Suppliers

Recommended suppliersmore

1150311-30-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1150311-30-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,0,3,1 and 1 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1150311-30:
(9*1)+(8*1)+(7*5)+(6*0)+(5*3)+(4*1)+(3*1)+(2*3)+(1*0)=80
80 % 10 = 0
So 1150311-30-0 is a valid CAS Registry Number.

1150311-30-0Upstream product

1150311-30-0Downstream Products

1150311-30-0Relevant articles and documents

Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands

Lee, Suk Ho,Seo, Hee Jeong,Kim, Min Ju,Kang, Suk Youn,Song, Kwang-Seop,Lee, Sung-Han,Jung, Myung Eun,Kim, Jeongmin,Lee, Jinhwa

scheme or table, p. 1899 - 1902 (2009/11/30)

Cannabinoid CB-1 receptors have been the focus of extensive studies since the first clinical results of rimonabant (SR141716) for the treatment of obesity and obesity-related metabolic disorders were reported in 2001. To further evaluate the properties of

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1150311-30-0